Cite
HARVARD Citation
Cheng, Y. et al. (n.d.). Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β‐hydroxysteroid dehydrogenase type‐1 inhibitor BMS‐823778. British journal of clinical pharmacology. pp. 130-141. [Online].